Registration Statement · S-1
Emergent Biosolutions, Inc.
EBSNYSEEQUITYCurrent
Registration Statement
Company context
Joseph Papa President and Chief Executive Officer Richard Lindahl EVP, Chief Financial Officer and Treasurer Jessica Perl SVP, General Counsel and Corporate Secretary Paul Williams SVP, Products Business Coleen Glessner EVP, Quality, Ethics and Compliance Simon Lowry, M.D. Chief Medical Officer, Head of Research and Development Stephanie Duatschek SVP, Chief Strategy and Transformation Officer Michelle Pepin SVP, Chief Human Resources Officer Bill Hartzel SVP, Manufacturing and Bioservices Emergent’s Executive Management Team
Current securities
Recent company filings
- SCHEDULE 13G/A - filed by OAK HILL ADVISORS LP regarding Emergent BioSolutions Inc.Nov 16, 2026
- SCHEDULE 13G/A - filed by AMERICAN CENTURY INVESTMENT MANAGEMENT INC regarding Emergent BioSolutions Inc.Nov 16, 2026
- Other EventsNov 4, 2026
- 10-Q filingNov 3, 2026
- Results of Operations and Financial Condition · Regulation FD DisclosureNov 2, 2026
As-filed source
As filedOpen full document ↗